Sign in Browse medications

Learn

Clear answers before clinical review.

Plain-language education on GLP-1 care, peptide therapy, nutrition, pharmacy quality, and the safety questions a clinician reviews before prescribing.

Where a therapy is in the regulatory journey

Preclinical developmentPhase 1 · investigationalPhase 2 · investigationalPhase 3 · investigationalApplication submittedFDA application reviewFDA-approved product

Tags describe the named therapy and use at the review date, not the age or design of a cited paper. Development can stop or change; phase 3 results do not imply an application is submitted or under FDA review. Designations support development and are separate from approval. Approval applies to a specific product and indication, not to compounded preparations. General care articles may cover multiple stages and have no single therapy tag.

Cancer researchGLP-1Patient careWeight ManagementLongevityRecoveryCellular HealthPeptidesHair & SkinPharmacy Standards

Cancer research

Phase 3 · investigationalOrphan drug designation · not approval

RYZ101 · GEP-NETs; investigational, not FDA approved · Status checked 2026-10-14

Can a Peptide Target Cancer? RYZ101 and the ACTION-1 Study

A peptide guides an investigational radioactive therapy to tumor receptors. What the phase 3 ACTION-1 announcement shows—and what remains unanswered.

Online GLP-1 Consultation: What to Prepare and Ask

Prepare for an online weight-management consultation with a practical checklist of records, questions, costs, and follow-up expectations.

How to Evaluate an Online Peptide Therapy Provider

Questions to ask about clinician credentials, evidence, pharmacy fulfillment, pricing, and follow-up before requesting peptide care online.

FDA-approved product

Wegovy · labeled weight-management use; compounded products are not FDA approved · Status checked 2026-10-14

What Is Semaglutide?

A practical guide to how semaglutide works, why clinician screening matters, and what patients should understand before starting.

FDA-approved product

Zepbound · labeled weight-management use; compounded products are not FDA approved · Status checked 2026-10-14

What Is Tirzepatide?

How dual GIP/GLP-1 signaling differs from older metabolic medications and why dose selection should be individualized.

Weight Management

Semaglutide vs Tirzepatide

A patient-friendly comparison of two major metabolic therapy pathways and the factors that shape physician selection.

What Is NAD+?

NAD+ is central to cellular energetics, but human evidence is mainly biochemical and early physiologic rather than proof of longevity or disease-prevention benefit.

What Is Sermorelin?

Sermorelin is a growth-hormone secretagogue used in clinician-guided protocols for selected patients.

Cellular Health

What Is Glutathione?

A grounded overview of glutathione, oxidative stress, route considerations, and safety screening.

Peptide Therapy: What Patients Should Know

The practical difference between physician-prescribed peptide therapy and self-sourced research compounds.

Weight Management

What to Eat While Taking a GLP-1

Protein, hydration, fiber, and resistance training become more important when appetite drops.

GLP-1 Side Effects: What Is Common and What Needs Attention

Nausea, constipation, reflux, and appetite changes are common. Severe or persistent symptoms need clinical review.

Weight Management

GLP-1 Maintenance: What Happens After Weight Loss?

Long-term metabolic care is about maintenance, dose strategy, nutrition, strength, and realistic follow-up.

Phase 2 · investigational

BPC-157 · registered phase 2 research; no FDA-approved product · Status checked 2026-10-14

What Is BPC-157?

BPC-157 is discussed in recovery and tissue-support settings, but human evidence is limited and expectations should stay careful.

What Is TB-500?

TB-500 is often discussed alongside recovery protocols. Here is how to think about mechanism, evidence, and safety review.

What Is GHK-Cu?

GHK-Cu is a copper peptide discussed in skin and hair-support protocols, with expectations that should stay measured.

CJC-1295 / Ipamorelin: What Patients Should Know

Growth-hormone secretagogue protocols require endocrine context, realistic goals, and clinician monitoring.

What Is Epitalon?

Epitalon is a small pineal peptide discussed for sleep, circadian rhythm, and healthy aging. Here is what the research shows, and what it does not.

What Is SS-31 (Elamipretide)?

SS-31 is a mitochondria-targeted peptide discussed for energy, endurance, and recovery. Here is how it works, what the evidence covers, and who should be careful.

Pharmacy Standards

How to Think About Compounded Pharmacy Quality

503A and 503B pharmacy language can be confusing. Patients should understand what compounding does and does not mean.

Weight Management

Phase 3 · investigational

Retatrutide · clinical development; not FDA approved · Status checked 2026-10-14

What Is Retatrutide?

Retatrutide is a triple-receptor agonist discussed in metabolic research. Availability and appropriateness require careful review.

Ready for clinical review?

Education first. Prescription only when appropriate.

Learn what to ask, then complete the medical intake when you are ready to request physician-guided care.

Browse medications